Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-02-04T17:31:06.987Z Has data issue: false hasContentIssue false
  • English
  • Français

The distribution of antibodies to HHV-6 compared with other herpesviruses in young children

Published online by Cambridge University Press:  15 May 2009

T. J. Farr ,
G. B. Harnett ,
G. R. Pietroboni  and
M. R. Bucens
T. J. Farr
Affiliation:
Virus Laboratory, Combined Microbiology Service, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, 6009
G. B. Harnett*
Affiliation:
Virus Laboratory, Combined Microbiology Service, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, 6009
G. R. Pietroboni
Affiliation:
Virus Laboratory, Combined Microbiology Service, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, 6009
M. R. Bucens
Affiliation:
Virus Laboratory, Combined Microbiology Service, Queen Elizabeth II Medical Centre, Nedlands, Western Australia, 6009
*
* Author for reprints and correspondence: Dr G. B. Harnett, Virus Laboratory, Combined Microbiology Service, GPO. Box F132, Perth, Western Australia, 6001.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Sera from 141 infants aged 0–12 months were examined for IgG antibodies to HHV-6, HSV, CMV, VZV and EBV and for HHV-6 specific IgM. Following the decline in maternal antibody, antibody to HHV-6 was found to rise by 5–6 months and approached the level found in adults by 11–12 months. In contrast the antibody rates for the other herpesviruses were much slower to rise, especially in the case of CMV and EBV. HHV-6 IgM antibodies were detected mainly in age groups showing a rapid rise in antibody to HHV-6. HHV-6-IgM was not detected in 235 cord blood samples. The data suggest that HHV-6 infection is acquired horizontally, at a very early age in Western Australia.

Type
Research Article
Information
Epidemiology & Infection , Volume 105 , Issue 3 , December 1990 , pp. 603 - 607
Copyright
Copyright © Cambridge University Press 1990

References

REFERENCES

1.Salahuddin, SZ, Ablashi, DV, Markham, PD et al. , Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596–601.CrossRefGoogle ScholarPubMed
2.Ablashi, DV, Salahuddin, SZ, Josephs, SF, Imam, F, Gallo, RC. HBLV (or HHV-6) in human cell lines. Nature 1987; 329: 207.CrossRefGoogle ScholarPubMed
3.Lopez, C, Pellet, P, Stewart, J et al. , Characteristics of human herpesvirus-6. J Infect Dis 1988; 157: 1271–3.CrossRefGoogle ScholarPubMed
4.Pietroboni, GR, Harnett, GB, Bucens, MR, Honess, RW. Human herpesvirus 6 in saliva. Lancet 1988; i: 1059.CrossRefGoogle Scholar
5.Harnett, GB, Farr, TJ, Pietroboni, GR, Bucens, MR. Human herpesvirus 6 (HHV-6): Frequent shedding in saliva. J Med Virol 1990; 30: 128–30.CrossRefGoogle ScholarPubMed
6.Tedder, RS, Briggs, M, Cameron, CH, Honess, R, Robertson, D, Whittle, H. A novel lymphotropic herpesvirus. Lancet 1987; ii: 390–2.CrossRefGoogle Scholar
7.Saxinger, C, Polesky, H, Eby, N et al. , Antibody reactivity with HBLV (HHV-6) in U.S. populations. J Virol Methods 1988; 21: 199–208.CrossRefGoogle ScholarPubMed
8.Pietroboni, GR, Harnett, GB, Farr, TJ, Bucens, MR. Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV). J Clin Pathol 1988; 41: 1310–2.CrossRefGoogle ScholarPubMed
9.Pietroboni, GR, Harnett, GB, Bucens, MR. Centrifugal enhancement of human immuno-deficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro. J Virol Methods 1989; 24: 85–90.CrossRefGoogle Scholar
10.Kerbel, RS. Herpes virus induction of Fc receptors. Nature 1976; 263: 192.CrossRefGoogle Scholar
11.Harnett, GB, Palmer, CA, Bucens, MR. A modified immunofluorescence test for Epstein-Barr virus-specific IgM antibody. J Virol Methods 1985; 12: 25–30.CrossRefGoogle ScholarPubMed
12.Okuno, T, Takahashi, K, Balachandra, K et al. , Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J Clin Microbiol 1989; 27: 651–3.CrossRefGoogle ScholarPubMed
13.Yamanishi, JK, Okuno, T, Shiraki, K et al. , Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; i: 1065–7.CrossRefGoogle Scholar
14.Kirchesch, H, Mertens, T, Burkhardt, U, Kruppenbacher, JP, Hoffken, A, Eggers, HJ. Seroconversion against human herpesvirus-6 (and other herpesviruses) and clinical illness. Lancet 1988; ii: 273–4.CrossRefGoogle Scholar